RECRUITINGOBSERVATIONAL
A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.
A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.
About This Trial
By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
- Age: over 18 years old;
- There are sufficient remaining serum samples and extensive willing to sign a consent form has been signed.
Who Should NOT Join This Trial:
- Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases；
- Improper storage or repeated freeze-thaw of remaining serum samples.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients attending the outpatient/emergency/inpatient department of Zhujiang Hospital;
* Age: over 18 years old;
* There are sufficient remaining serum samples and extensive informed consent has been signed.
Exclusion Criteria:
* Early diagnosis of hematological diseases such as plasma cell or other B lymphocyte proliferative diseases；
* Improper storage or repeated freeze-thaw of remaining serum samples.
Locations (1)
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China